Preparing your case review…
Written By
People's Justice Legal Research Team
Statute of Limitations
Kansas: 2 years from discovery (K.S.A. § 60-513)
2 years from BIA-ALCL diagnosis or discovery of BIOCELL injury connection
Filing Venue
Where to File in Kansas
Kansas plaintiffs with Allergan BIOCELL claims file in MDL 2921 in the District of New Jersey. Kansas applies a 2-year personal injury statute under K.S.A. § 60-513 with the discovery rule. Wichita and the Kansas City metro area (covering both Kansas and Missouri) placed Allergan BIOCELL products during the 2005–2019 period. Kansas plaintiffs with BIA-ALCL diagnoses from 2024 onward are within the limitations window.
Kansas Data
Exposure in Kansas
Source: FDA MAUDE Adverse Event Database
Source: Allergan/AbbVie; FDA Safety Communication